Standout Papers

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatme... 2004 2026 2011 2018 1.4k
  1. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial (2004)
    Lars Klareskog, Désirée van der Heijde et al. The Lancet
  2. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review (2007)
    Daniel E. Tracey, Lars Klareskog et al. Pharmacology & Therapeutics
  3. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination (2005)
    Lars Klareskog, Patrik Stolt et al. Arthritis & Rheumatism
  4. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis (2006)
    Eva Baecklund, Anastasia Iliadou et al. Arthritis & Rheumatism
  5. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis (2013)
    Yun Liu, Martin J. Aryee et al. Nature Biotechnology
  6. Rheumatoid arthritis (2009)
    Lars Klareskog, Anca I. Catrina et al. The Lancet
  7. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis (2012)
    Soumya Raychaudhuri, Cynthia Sandor et al. Nature Genetics
  8. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2006)
    Bernard Combe, R. B. M. Landewé et al. Annals of the Rheumatic Diseases
  9. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin (2012)
    Ulrike Harre, Dan Georgess et al. Journal of Clinical Investigation
  10. Incidence of Cancer Among Patients With Rheumatoid Arthritis (1993)
    Gloria Gridley, J. K. McLaughlin et al. JNCI Journal of the National Cancer Institute
  11. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (2008)
    Edward Keystone, Mark C. Genovese et al. Annals of the Rheumatic Diseases
  12. Epidermal Langerhans cells express Ia antigens (1977)
    Lars Klareskog, Urban Forsum et al. Nature
  13. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting (2016)
    Vivianne Malmström, Anca I. Catrina et al. Nature reviews. Immunology

Immediate Impact

12 by Nobel laureates 24 from Science/Nature 68 standout
Sub-graph 1 of 20

Citing Papers

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
2023 Standout

Works of Lars Klareskog being referenced

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis
2012 Standout
Mechanisms of Disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis
2006
and 6 more

Author Peers

Author Last Decade Papers Cites
Lars Klareskog 21624 7958 13668 653 41.5k
T. Huizinga 27698 8407 14454 1.1k 48.2k
David Isenberg 27187 11393 22345 950 44.7k
Peter E. Lipsky 13513 6609 22950 652 45.8k
Marc Feldmann 15252 7367 23651 554 52.9k
Ravinder N. Maini 16776 5017 10060 265 30.7k
Yehuda Shoenfeld 22447 6742 19589 1.6k 60.8k
Josef S Smolen 24872 3532 9923 505 34.4k
Paul P. Tak 13649 3354 11501 451 32.6k
Yoshiya Tanaka 14001 2902 9387 1.1k 29.3k
Michael E. Weinblatt 16810 2794 7260 374 33.1k

All Works

Loading papers...

Rankless by CCL
2026